Quick10K

⚲

Phillips Edison

Filings

10-Q	2020-06-30	Filed 2020-08-13
10-Q	2020-03-31	Filed 2020-05-12
10-K	2019-12-31	Filed 2020-03-12
10-Q	2019-09-30	Filed 2019-11-07
10-Q	2019-06-30	Filed 2019-08-12
10-Q	2019-03-31	Filed 2019-05-10
10-K	2018-12-31	Filed 2019-03-13
10-Q	2018-09-30	Filed 2018-11-05
10-Q	2018-06-30	Filed 2018-08-10
10-Q	2018-03-31	Filed 2018-05-10
10-K	2017-12-31	Filed 2018-03-30
10-Q	2017-09-30	Filed 2017-11-09
10-Q	2017-06-30	Filed 2017-08-09
10-Q	2017-03-31	Filed 2017-05-11
10-K	2016-12-31	Filed 2017-03-09
10-Q	2016-09-30	Filed 2016-11-03
10-Q	2016-06-30	Filed 2016-08-04
10-Q	2016-03-31	Filed 2016-05-05
10-K	2015-12-31	Filed 2016-03-03
10-Q	2015-09-30	Filed 2015-11-12
10-Q	2015-06-30	Filed 2015-08-06
10-Q	2015-03-31	Filed 2015-05-07
10-K	2014-12-31	Filed 2015-03-09
10-Q	2014-09-30	Filed 2014-11-05
10-Q	2014-06-30	Filed 2014-08-07
10-Q	2014-03-31	Filed 2014-05-08
10-K	2013-12-31	Filed 2014-03-13
10-Q	2013-09-30	Filed 2013-11-08
10-Q	2013-06-30	Filed 2013-08-08
10-Q	2013-03-31	Filed 2013-05-09
10-K	2012-12-31	Filed 2013-03-07
10-Q	2012-09-30	Filed 2012-11-08
10-Q	2012-06-30	Filed 2012-08-10
10-Q	2012-03-31	Filed 2012-05-11
10-K	2011-12-31	Filed 2012-03-23
10-Q	2011-09-30	Filed 2011-11-14
10-Q	2011-06-30	Filed 2011-08-11
10-Q	2011-03-31	Filed 2011-05-13
10-K	2010-12-31	Filed 2011-03-30
10-Q	2010-09-30	Filed 2010-11-12
10-Q	2010-06-30	Filed 2010-09-24

Reports

8-K	2020-08-12	Earnings, Regulation FD, Exhibits
8-K	2020-08-04	Amend Bylaw, Shareholder Vote, Exhibits
8-K	2020-07-14	Regulation FD, Exhibits
8-K	2020-06-17
8-K	2020-06-10
8-K	2020-05-12
8-K	2020-04-15
8-K	2020-03-27
8-K	2020-02-24
8-K	2020-01-08
8-K	2019-11-06
8-K	2019-08-12
8-K	2019-06-12
8-K	2019-05-09
8-K	2019-04-01
8-K	2019-03-12
8-K	2018-11-16
8-K	2018-11-05
8-K	2018-08-08
8-K	2018-08-06
8-K	2018-07-19
8-K	2018-07-17
8-K	2018-05-10
8-K	2018-05-09
8-K	2018-03-14

Phillips Edison Financials

PHLD Metrics, Comps, Filings

Quarterly | Annual

Valuation ($BB)

Market Cap, Enterprise Value

Balance Sheet ($BB)

Assets, Equity

Income Statement ($BB Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($BB Quarterly)

Ops, Inv, Fin


Comps ($MM TTM)	Market Cap	Gross Margin	EV/EBITDA	Ret on Assets	Assets	Liabilities	Revenue	G Profit	Net Income	EBITDA	EV
Yummies (YUMM)			-1.8	54%	0	0	0	0	0	0	-0
Alliancebernstein (ABLP)		0%	-0.9	8%	8,555	4,398	2,578	0	713	790	-722
Liberty Expedia (LEXE)		0%	0.0	-0%	34,646	17,341	11,536	0	-148	994	8
Real Estate Associates IV (REAL4)			-0.0	-32%	0	0	0	0	-0	0	-0
Apawthecary Pets (APAW)			0.8	-97%	0	0	0	0	-0	-0	-0
SKY Resort (SKYL)			0.0	-5,741%	0	0	0	0	-0	-0	-0
AEI Income & Growth Fund XXI (AEI21)			-1.4	2%	11	0	0	0	0	1	-1
Fraud Protection Network (FPNI)		0%	-1.4	-208%	1	2	1	0	-2	-1	2
iShares Gold Trust (IAU)			-0.0	-185,563,862,900%			0	0	1,856	1,856	-0
Federal Home Loan Bank of Dallas (FHLBD)			-0.1	0%	73,781	70,071	0	0	166	1,357	-153
Galenfeha (GLFH)				-0%			0	0	0	0	2
Rasna Therapeutics (RASP)			0.0	-26%	5	2	0	0	-1	-1	-0
Osprey Technology (SFTW)			33.4	-0%	0	0	0	0	-0	-0	-0
CLIC Technology (CLIC)			-2.2	-121%	0	2	0	0	-1	-1	1
Campbell Strategic Allocation Fund (CSAF)			-1.3	14%	193	5	0	0	27	27	-35
Golden Star Resource (GLNS)			0.0	-718%	0	1	0	0	-0	-0	-0
Richmond Mutual Bancorporation (RMBI)			-5.9	-0%	956	756	0	0	-2	7	-41
Toyota Motor Credit (TMCC)			-0.8	1%	119,938	105,527	0	552	1,327	4,343	-3,605
DJO Finance (DJO)		0%	12.6	0%	2,012	2,866	1,204	0	1	189	2,394
Stoke Therapeutics (STOK)			14.2	-7%	239	5	0	0	-16	-16	-233


Balance Sheet ($MM)	2011-06-30	2011-09-30	2011-12-31	2012-03-31	2012-06-30	2012-09-30	2013-03-31	2013-06-30	2013-09-30	2013-12-31	2014-03-31	2014-06-30	2014-09-30	2014-12-31	2015-03-31	2015-06-30	2015-09-30	2015-12-31	2016-03-31	2016-06-30	2016-09-30	2016-12-31	2017-03-31	2017-06-30	2017-09-30	2017-12-31	2018-03-31	2018-06-30	2018-09-30	2018-12-31	2019-03-31	2019-06-30	2019-09-30
Cash	0	0	7	6	12	16	8	62	326	460	257	20	20	16	14	33	20	41	11	7	21	8	6	5	7	22	32	25	34	84	87	53	86
Accounts Receivable	0	0	1	1	1	2	4	6	10	13	14	18	21													41	40	36	37	56	44	51	43
Inventory
PP&E	27	27	69	80	126	206	433	595	776	1,107	1,351	1,636	1,784	2,074	2,139	2,143	2,133	2,118	2,094	2,173	2,191	2,250	2,241	2,314	2,329	3,290	3,264	3,205	3,154	4,815	4,736	4,698	4,525
Assets	32	32	85	95	152	243	490	730	1,204	1,722	1,796	1,865	2,025	2,151	2,217	2,242	2,224	2,235	2,172	2,247	2,285	2,380	2,342	2,411	2,449	3,526	3,519	3,452	3,418	5,163	5,057	4,976	4,895
Accounts Payable
Long-Term Debt					70	128	253	210	216			354	519	643	722	763	781	854	819	902	955	1,061	1,084	1,176	1,232	1,818	1,845	1,848	1,853	2,461	2,437	2,443	2,441
Liabilities	27	24	58	51	81	143	271	235	253	252	341	427	600	743	818	856	877	943	903	998	1,050	1,155	1,171	1,270	1,341	2,047	2,058	2,067	2,079	2,751	2,708	2,734	2,747
Stockholders' Equity	5	8	14	24	38	63	175	452	910	1,469	1,455	1,438	1,392	1,355	1,288	1,308	1,291	1,267	1,244	1,225	1,210	1,201	1,147	1,119	1,091	1,046	1,033	965	928	1,998	1,951	1,871	1,787


Income Statement ($MM)	2011-06-30	2011-09-30	2011-12-31	2012-03-31	2012-06-30	2012-09-30	2013-03-31	2013-06-30	2013-09-30	2013-12-31	2014-03-31	2014-06-30	2014-09-30	2014-12-31	2015-03-31	2015-06-30	2015-09-30	2015-12-31	2016-03-31	2016-06-30	2016-09-30	2016-12-31	2017-03-31	2017-06-30	2017-09-30	2017-12-31	2018-03-31	2018-06-30	2018-09-30	2018-12-31	2019-03-31	2019-06-30	2019-09-30
Revenue	1	1	1	2	3	5	11	15	20	27	36	59	50	59	59	59	62	62	63	63	65	66	68	70	71	103	103	104	105	118	133	133	136
Cost of Revenue
Gross Profit
R&D
SG&A	0	0	0	0	0	1	1	1	1	2	2	2	2	2	2	3	3	8	8	8	8	8	8	9	9	11	10	13	14		13	14	12
Tax
Net Income	-1	-0	-1	-0	-1	-1	-3	-2	-1	-6	-0	-1	2	-22	5	5	5	-2	2	1	2	4	1	-1	-8	-30	-2	-11	-13	65	-5	-37	-26


Cash Flow ($MM)	2011-06-30	2011-09-30	2011-12-31	2012-03-31	2012-06-30	2012-09-30	2013-03-31	2013-06-30	2013-09-30	2013-12-31	2014-03-31	2014-06-30	2014-09-30	2014-12-31	2015-03-31	2015-06-30	2015-09-30	2015-12-31	2016-03-31	2016-06-30	2016-09-30	2016-12-31	2017-03-31	2017-06-30	2017-09-30	2017-12-31	2018-03-31	2018-06-30	2018-09-30	2018-12-31	2019-03-31	2019-06-30	2019-09-30
Cash Operating		1	0	-1	1	2	4	5	7	3	16	19	24	17	29	35	27	15	25	32	28	18	20	29	19	41	24	54	44		41	59	76
Cash Investing		-0	-46	-11	-46	-55	-124	-168	-172	-313	-204	-254	-125	-132	-65	-33	-4	-8	-4	-101	-44	-77	15	-65	-47	-523	-17	4	-3		28	-55	18
Cash Financing		-0	52	11	50	57	120	217	429	444	-15	-2	101	111	35	17	-36	13	-51	64	30	46	-38	36	31	481	-2	-65	-32		-67	-38	-60